Prezident společnosti Hisense Americas David Gold ve svém vystoupení potvrdil odhodlání společnosti Hisense sbližovat svět integrováním zobrazovacích technologií do běžného života. LAS VEGAS, 10. ledna 2024 /PRNewswire/ — Globální společnost Hisense, výrobce elektronických produktů a domácích spotřebičů, představila na veletrhu CES 2024 nové produkty a nastínila budoucnost této značky. David Gold, prezident společnosti Hisense Americas, ve… Continue reading SPOLEČNOST HISENSE NA VELETRHU CES 2024 POSOUVÁ HRANICE MOŽNOSTÍ ZOBRAZOVACÍCH TECHNOLOGIÍ A ŽIVOTA NA BÁZI KONKRÉTNÍCH SITUACÍ
Category: Newswire
Dstny wins Best Use of Telephony / Unified Communications in the 2023-2024 Cloud Awards
LONDON, Jan. 10, 2024 /PRNewswire/ — Dstny has emerged victorious in the 2023 – 2024 Cloud Awards, securing the title of Best Use of Telephony/Unified Communications with its newly released product Call2Teams Go. Call2Teams Go is the latest addition to Dstny’s Call2Teams product set – which offers one of the most cost-effective solutions on the… Continue reading Dstny wins Best Use of Telephony / Unified Communications in the 2023-2024 Cloud Awards
Dstny wins Best Use of Telephony / Unified Communications in the 2023-2024 Cloud Awards
LONDON, Jan. 10, 2024 /PRNewswire/ — Dstny has emerged victorious in the 2023 – 2024 Cloud Awards, securing the title of Best Use of Telephony/Unified Communications with its newly released product Call2Teams Go. Call2Teams Go is the latest addition to Dstny’s Call2Teams product set – which offers one of the most cost-effective solutions on the… Continue reading Dstny wins Best Use of Telephony / Unified Communications in the 2023-2024 Cloud Awards
New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA
HONG KONG, Jan. 10, 2024 /PRNewswire/ — The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has developed a new drug using effective components of a Chinese herbal medicine, Chaenomelis Fructus, for the treatment of the rare disease, myofibrillar myopathy. The drug has obtained the orphan drug designation from the US Food and… Continue reading New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA
Laminated Busbar Market worth $1,296 million by 2030 – Exclusive Report by MarketsandMarkets™
CHICAGO, Jan. 10, 2024 /PRNewswire/ — Laminated Busbar Market is expected to reach USD 1,296 million by 2030 from USD 863 million in 2023 at a CAGR of 6.0% during the 2023–2030 period according to a new report by MarketsandMarkets™. The Laminated Busbar Market is set for significant expansion in the coming years, driven primarily by the advancement… Continue reading Laminated Busbar Market worth $1,296 million by 2030 – Exclusive Report by MarketsandMarkets™
Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma
BERLIN, Jan. 10, 2024 /PRNewswire/ — Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces it has submitted an application with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to undertake a Phase 1 trial of 123I-ATT001, its Iodine-123 labelled PARP inhibitor in… Continue reading Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma
42Com partners with Vladimir Smal to redefine trusted SMS with their new venture ‘AVISO Messaging’
42com and Vladimir Smal are introducing AVISO Messaging, a strategic initiative answering the industry’s demand for integrity and elevated quality in messaging services. LONDON, Jan. 10, 2024 /PRNewswire/ — In a strategic move that underscores its commitment to innovation and quality, 42Com, a global voice wholesale specialist, has partnered with Vladimir Smal, to launch AVISO Messaging.… Continue reading 42Com partners with Vladimir Smal to redefine trusted SMS with their new venture ‘AVISO Messaging’
These Are the World’s Most (and Least) Powerful Passports in 2024
LONDON, Jan. 10, 2024 /PRNewswire/ — An unprecedented six countries share the top spot with visa-free access to a record-breaking number of destinations on the 2024 Henley Passport Index, which is based on exclusive and official data from the International Air Transport Association (IATA). Four EU member states — France, Germany, Italy, and Spain — join… Continue reading These Are the World’s Most (and Least) Powerful Passports in 2024
Philippine Airlines employees fly high with IBS Software’s iFly Staff
MANILA, Philippines, Jan. 10, 2024 /PRNewswire/ — Philippine Airlines (PAL) and its affiliate carrier, PAL Express (PALex), have embarked on the next phase of their journey to deploy IBS Software’s iFly Staff travel solution. Continue Reading IBS Software to manage staff travel at Philippine Airlines Built to improve travel operational efficiency for airline employee travellers, iFly Staff… Continue reading Philippine Airlines employees fly high with IBS Software’s iFly Staff
Hyundai Motor Exhibition at CES 2024 Envisions Transition to Hydrogen Energy and Software-Defined Mobility Solutions
Exhibition at the Las Vegas Convention Center, West Hall displays its vision for a hydrogen-powered, software-driven transformation and Group-wide technologies Hyundai Motor Group announces fuel cell system brand HTWO’s expansion into hydrogen value chain business brand Reveals software-defined vehicle (SDV) technologies under development to lead to a ‘Software-defined Everything’ (SDx) ecosystem beyond mobility Presents future mobilities (e.g.,… Continue reading Hyundai Motor Exhibition at CES 2024 Envisions Transition to Hydrogen Energy and Software-Defined Mobility Solutions